Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis
BMC Microbiology · 04.09.2024 · 24 (1)
DOI: 10.1186/s12866-024-03474-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 04.09.2024. Verfasst von Sharumathi Jeyasankar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Indian Institute of Science, Bengaluru, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Mycobacteriophages, Phage Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioengineering, Indian Institute of Science, Bengaluru, India.
- Department of Bioengineering, Indian Institute of Science, Bengaluru, India. rachit@iisc.ac.in.
Förderung
- Bill and Melinda Gates Foundation
Zitieren
APA
Jeyasankar, S., Kalapala, Y. C., Sharma, P. R., & Agarwal, R. (2024). Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03474-3
Vancouver
Jeyasankar S, Kalapala YC, Sharma PR, Agarwal R. Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03474-3
BibTeX
@article{Jeyasankar2024,
author = {Jeyasankar, Sharumathi and Kalapala, Yeswanth Chakravarthy and Sharma, Pallavi Raj and Agarwal, Rachit},
title = {Antibacterial efficacy of mycobacteriophages against virulent Mycobacterium tuberculosis},
journal = {BMC Microbiology},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12866-024-03474-3}
}
EUVIMED